SSI Strategy

SSI Strategy is a boutique management consulting company with unique expertise in innovative medicines; designing and implementing custom-tailored strategies for biotechs at any stage of company maturity.

SSI Strategy is a boutique management consulting company specialising in the design and implementation of custom, tailored strategies for life sciences organisations with unique expertise in Advanced Therapeutic Medicinal Products (ATMP).

SSI Strategy has designed a new model for supporting the needs of the scientific functions within life science companies. Its blended teams of experienced medical experts and management consultants combine business acumen, life science domain expertise, and operating experience to provide unparalleled support to our client’s needs.

SSI Strategy build fit for purposes strategies to support the needs of the medical organisation, which enables overall corporate objectives/milestones to be achieved. Their capabilities include creating and executing an overall medical strategy, non-clinical to clinical translational plans, designing and/or redesigning a clinical development plan and supporting investor related and/or board of director narratives, among other mission-critical competencies.

SSI Strategy have unique experience supporting innovative medicines companies at all key stages of their development (from pre-seed to launch and M&A). They understand the need for key value inflection points/ stakeholder engagement e.g Pre-IND, IND/CTA, innovative regulatory pathways (e.g ILAP) and HTA engagement.